Latest filingAug 19, 2026Most recent Form 4
ACON
Aclarion, Inc.
NasdaqHealthcareServices-Medical Laboratories
Insider activity for last month from 08/04 to 09/04. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$10.7M5 buys
Total selling$00 sells
Net open-market+$10.7M5 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period5transactions
- P · Open-market buys · dominant5 · 100%
Activity by reported role
A joint filing can contribute to multiple roles5transactions
- Director · dominant3 · 60%
- Chief executive officer1 · 20%
- Chief financial officer1 · 20%
Distinct insiders active
Reporting-owner CIKs by month · peak Aug 2026 (5)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeNess BrentCommon Stock · Direct
111,534Aug 13, 2026
Wesemann WilliamCommon Stock · Direct
23,713Aug 13, 2026
Bond RyanCommon Stock · Direct
76,122Aug 13, 2026
Gould Gregory ACommon Stock · Direct
60,000Aug 14, 2026
Williams Amanda MCommon Stock · Direct
25,857Aug 17, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 04 → Sep 04
LessMore
Top insiders
By absolute net value across the selected period- BR+$50.1k
- GA+$24.5k
- WM+$16.0k
- NB+$12.1k
- WW+$5.0k
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
ACON transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| ACON | Williams Amanda M | DIR | buy | 5.85k | $1.59M | P | −15.9% | 08/19 | 08/17 | |
| ACON | Gould Gregory A | CFO | buy | 10.0k | $2.45M | P | −10.4% | 08/18 | 08/14 | |
| ACON | Bond Ryan | DIR | buy | 21.1k | $5.00M | P | −15.9% | 08/17 | 08/13 | |
| ACON | Wesemann William | DIR | buy | 2.15k | $503k | P | −15.9% | 08/17 | 08/13 | |
| ACON | Ness Brent | CEO | buy | 5.23k | $1.20M | P | −15.9% | 08/17 | 08/13 |
Aclarion, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Aclarion, Inc.?
Williams Amanda M, Gould Gregory A, Bond Ryan, Wesemann William, Ness Brent.
When was the latest reported open-market purchase?
Williams Amanda M reported a buy on Aug 17, 2026 valued at $1.59M. Read the SEC filing.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
Net open-market buying in the selected period was $107,670.29. This describes filed transactions, not a bullish rating.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.